136 related articles for article (PubMed ID: 15257092)
1. Protection against an Escherichia coli-induced sepsis by alkaline phosphatase in mice.
Verweij WR; Bentala H; Huizinga-van der Vlag A; Miek van Loenen-Weemaes A; Kooi K; Meijer DK; Poelstra K
Shock; 2004 Aug; 22(2):174-9. PubMed ID: 15257092
[TBL] [Abstract][Full Text] [Related]
2. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide.
Bentala H; Verweij WR; Huizinga-Van der Vlag A; van Loenen-Weemaes AM; Meijer DK; Poelstra K
Shock; 2002 Dec; 18(6):561-6. PubMed ID: 12462566
[TBL] [Abstract][Full Text] [Related]
3. Detrimental effects of a nitric oxide synthase inhibitor (N-omega-nitro-L-arginine-methyl-ester) in a murine sepsis model.
Fukatsu K; Saito H; Fukushima R; Inoue T; Lin MT; Inaba T; Muto T
Arch Surg; 1995 Apr; 130(4):410-4. PubMed ID: 7710342
[TBL] [Abstract][Full Text] [Related]
4. Dephosphorylation of endotoxin by alkaline phosphatase in vivo.
Poelstra K; Bakker WW; Klok PA; Kamps JA; Hardonk MJ; Meijer DK
Am J Pathol; 1997 Oct; 151(4):1163-9. PubMed ID: 9327750
[TBL] [Abstract][Full Text] [Related]
5. Gene deletion of protein tyrosine phosphatase 1B protects against sepsis-induced cardiovascular dysfunction and mortality.
Coquerel D; Neviere R; Delile E; Mulder P; Marechal X; Montaigne D; Renet S; Remy-Jouet I; Gomez E; Henry JP; do Rego JC; Richard V; Tamion F
Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1032-44. PubMed ID: 24578383
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of splenic macrophage tumor necrosis factor alpha secretion in vivo by antilipopolysaccharide monoclonal antibodies.
Battafarano RJ; Burd RS; Kurrelmeyer KM; Ratz CA; Dunn DL
Arch Surg; 1994 Feb; 129(2):179-80. PubMed ID: 8304828
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human tissue non-specific alkaline phosphatase successfully counteracts lipopolysaccharide induced sepsis in mice.
Bender B; Baranyi M; Kerekes A; Bodrogi L; Brands R; Uhrin P; Bösze Z
Physiol Res; 2015; 64(5):731-8. PubMed ID: 25804104
[TBL] [Abstract][Full Text] [Related]
8. On the role and fate of LPS-dephosphorylating activity in the rat liver.
Tuin A; Huizinga-Van der Vlag A; van Loenen-Weemaes AM; Meijer DK; Poelstra K
Am J Physiol Gastrointest Liver Physiol; 2006 Feb; 290(2):G377-85. PubMed ID: 16223948
[TBL] [Abstract][Full Text] [Related]
9. Alkaline phosphatase treatment improves renal function in severe sepsis or septic shock patients.
Heemskerk S; Masereeuw R; Moesker O; Bouw MP; van der Hoeven JG; Peters WH; Russel FG; Pickkers P;
Crit Care Med; 2009 Feb; 37(2):417-23, e1. PubMed ID: 19114895
[TBL] [Abstract][Full Text] [Related]
10. Recombinant bovine soluble CD14 reduces severity of experimental Escherichia coli mastitis in mice.
Lee JW; Paape MJ; Zhao X
Vet Res; 2003; 34(3):307-16. PubMed ID: 12791240
[TBL] [Abstract][Full Text] [Related]
11. CD28 homodimer interface mimetic peptide acts as a preventive and therapeutic agent in models of severe bacterial sepsis and gram-negative bacterial peritonitis.
Ramachandran G; Kaempfer R; Chung CS; Shirvan A; Chahin AB; Palardy JE; Parejo NA; Chen Y; Whitford M; Arad G; Hillman D; Shemesh R; Blackwelder W; Ayala A; Cross AS; Opal SM
J Infect Dis; 2015 Mar; 211(6):995-1003. PubMed ID: 25305323
[TBL] [Abstract][Full Text] [Related]
12. Accelerated Aging and Clearance of Host Anti-inflammatory Enzymes by Discrete Pathogens Fuels Sepsis.
Yang WH; Heithoff DM; Aziz PV; Haslund-Gourley B; Westman JS; Narisawa S; Pinkerton AB; Millán JL; Nizet V; Mahan MJ; Marth JD
Cell Host Microbe; 2018 Oct; 24(4):500-513.e5. PubMed ID: 30308156
[TBL] [Abstract][Full Text] [Related]
13. A cell wall component from pathogenic and non-pathogenic gram-positive bacteria (peptidoglycan) synergises with endotoxin to cause the release of tumour necrosis factor-alpha, nitric oxide production, shock, and multiple organ injury/dysfunction in the rat.
Wray GM; Foster SJ; Hinds CJ; Thiemermann C
Shock; 2001 Feb; 15(2):135-42. PubMed ID: 11220642
[TBL] [Abstract][Full Text] [Related]
14. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
[TBL] [Abstract][Full Text] [Related]
15. Ghrelin protects mice against endotoxemia-induced acute kidney injury.
Wang W; Bansal S; Falk S; Ljubanovic D; Schrier R
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F1032-7. PubMed ID: 19625378
[TBL] [Abstract][Full Text] [Related]
16. Exogenous carbon monoxide suppresses Escherichia coli vitality and improves survival in an Escherichia coli-induced murine sepsis model.
Shen WC; Wang X; Qin WT; Qiu XF; Sun BW
Acta Pharmacol Sin; 2014 Dec; 35(12):1566-76. PubMed ID: 25399652
[TBL] [Abstract][Full Text] [Related]
17. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
18. Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression.
Metkar S; Awasthi S; Denamur E; Kim KS; Gangloff SC; Teichberg S; Haziot A; Silver J; Goyert SM
Infect Immun; 2007 Nov; 75(11):5415-24. PubMed ID: 17709409
[TBL] [Abstract][Full Text] [Related]
19. Calf intestinal alkaline phosphatase, a novel therapeutic drug for lipopolysaccharide (LPS)-mediated diseases, attenuates LPS toxicity in mice and piglets.
Beumer C; Wulferink M; Raaben W; Fiechter D; Brands R; Seinen W
J Pharmacol Exp Ther; 2003 Nov; 307(2):737-44. PubMed ID: 12970380
[TBL] [Abstract][Full Text] [Related]
20. Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase.
Komazin G; Maybin M; Woodard RW; Scior T; Schwudke D; Schombel U; Gisch N; Mamat U; Meredith TC
J Biol Chem; 2019 Dec; 294(50):19405-19423. PubMed ID: 31704704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
